Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) FCF Margin (2018 - 2025)

Neurogene (NGNE) has disclosed FCF Margin for 5 consecutive years, with 1881000.0% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, FCF Margin rose 187795422.0% year-over-year to 1881000.0%, compared with a TTM value of 96634.57% through Sep 2025, up 9189360.0%, and an annual FY2024 reading of 7711.24%, down 19136124.0% over the prior year.
  • FCF Margin was 1881000.0% for Q2 2025 at Neurogene, up from 26942.5% in the prior quarter.
  • Across five years, FCF Margin topped out at 1881000.0% in Q2 2025 and bottomed at 3045.78% in Q2 2024.